Cost-Effectiveness of a Clinical Childhood Obesity Intervention

Mona Sharifi1, Calvin Franz2, Christine M Horan3

  • 1Department of Pediatrics, Section of General Pediatrics, Yale University School of Medicine, New Haven, Connecticut; mona.sharifi@yale.edu.

Pediatrics
|November 2, 2017
PubMed

Insights

The Study of Technology to Accelerate Research (STAR) intervention for childhood obesity is a cost-effective strategy, potentially averting thousands of cases and improving public health outcomes.

Area of Science:

  • Public Health
  • Pediatric Medicine
  • Health Economics

Background:

  • Childhood obesity is a significant public health concern with long-term health and economic consequences.
  • Existing clinical interventions for childhood obesity have shown variable effectiveness and cost-efficiency.
  • The Study of Technology to Accelerate Research (STAR) intervention integrates electronic health record (EHR) decision support for clinicians with parent-focused behavior change support.

Purpose of the Study:

  • To evaluate the cost-effectiveness of a national implementation of the STAR intervention for childhood obesity.
  • To estimate the potential population impact of the STAR intervention on obesity prevalence.
  • To assess the economic viability of using EHR-based decision support in pediatric practices.

Main Methods:

  • A microsimulation model was developed to simulate the national implementation of the STAR intervention from 2015 to 2025.
  • The model included pediatric primary care providers with functional EHRs across the United States.
  • Key outcomes measured included intervention costs, changes in BMI, obesity prevalence, and cost-effectiveness metrics.

Main Results:

  • A 10-year national implementation is projected to reach approximately 2 million children.
  • The intervention is estimated to cost $119 per child and $237 per BMI unit reduced.
  • It is expected to avert 43,000 obesity cases and 226,000 life-years with obesity, at a net cost of $4085 per case and $774 per life-year.

Conclusions:

  • The STAR intervention demonstrates potential for greater cost-effectiveness compared to prior clinical childhood obesity interventions.
  • Integrating clinician decision support with parent-guided behavior change is a viable strategy.
  • This approach could complement population-level strategies to accelerate reductions in childhood obesity prevalence.
Abstract

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
489
Community Based Intervention01:30

Community Based Intervention

Community-based interventions in mental health represent a paradigm shift from institution-centered care to treatments embedded within the fabric of local communities. By prioritizing inclusion and leveraging existing societal structures, this approach fosters a supportive environment conducive to addressing mental health challenges while promoting individual dignity and agency.
Foundations of Community Mental Health Programs
Central to the success of community-based interventions is the...
498
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
208